These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 1708569)
1. [Importance of DNA-cytometric parameters in the prediction of blast crisis in the course of chronic myelogenous leukemia]. Kropff M; Wenzler T; Wagner A; Muller CP; Böcking A Verh Dtsch Ges Pathol; 1990; 74():126-9. PubMed ID: 1708569 [TBL] [Abstract][Full Text] [Related]
2. Monitoring DNA cytometric parameters during the course of chronic myelogenous leukemia. Kropff M; Chatelain R; Muller CP; Wagner A; Wenzler T; Böhmer H; Böcking A Anal Quant Cytol Histol; 1991 Dec; 13(6):433-9. PubMed ID: 1807286 [TBL] [Abstract][Full Text] [Related]
3. Detection of high risk patients in chronic myelogenous leukemia by DNA-image cytometry. Muller CP; Kropff M; Biesterfeld S; Chatelain R; Wagner A; Wohltmann D; Böcking A Anticancer Res; 1991; 11(2):617-23. PubMed ID: 2064316 [TBL] [Abstract][Full Text] [Related]
4. Lymphoid blast crisis of chronic myelogenous leukemia occurring more than 11 years after receiving an allogeneic bone marrow transplant for chronic myelogenous leukemia in myeloid blast crisis at onset. Fukuno K; Tsurumi H; Yamada T; Oyama M; Matsuyama T; Terakura S; Kodera Y; Moriwaki H Bone Marrow Transplant; 2003 Feb; 31(3):211-3. PubMed ID: 12621483 [TBL] [Abstract][Full Text] [Related]
5. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells]. Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781 [TBL] [Abstract][Full Text] [Related]
6. Predictors for prognosis of chronic myelocytic leukemia. Chen SS; Zhang HF; Xue WT; Li K; Wang P; Lui Y Chin Med J (Engl); 1993 Oct; 106(10):760-2. PubMed ID: 7913433 [TBL] [Abstract][Full Text] [Related]
7. Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model. Kometani K; Aoki M; Kawamata S; Shinozuka Y; Era T; Taniwaki M; Hattori M; Minato N Cancer Res; 2006 Oct; 66(20):9967-76. PubMed ID: 17047059 [TBL] [Abstract][Full Text] [Related]
8. [Enzymatic markers in chronic myeloleukemia and their importance for identifying a blast crisis]. Filanovskaia LI; Togo AV; Shcherbakova EG; Rogaleva EIu; Blinov MN Vopr Onkol; 1990; 36(9):1053-8. PubMed ID: 2122593 [TBL] [Abstract][Full Text] [Related]
9. Sudden onset of the blastic phase of chronic myelogenous leukemia: patterns and implications. Kantarjian H; O'Brien S; Cortes J; Giles F; Thomas D; Kornblau S; Shan J; Beth Rios M; Keating M; Freireich E; Talpaz M Cancer; 2003 Jul; 98(1):81-5. PubMed ID: 12833459 [TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of the blast phase of chronic granulocytic leukemia. Canellos GP Hematol Oncol Clin North Am; 1990 Apr; 4(2):359-67. PubMed ID: 2182596 [TBL] [Abstract][Full Text] [Related]
11. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia]. Okabe M Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066 [TBL] [Abstract][Full Text] [Related]
12. Stem cell regulation and the development of blast crisis in chronic myeloid leukemia: Implications for the outcome of Imatinib treatment and discontinuation. Wodarz D Med Hypotheses; 2008; 70(1):128-36. PubMed ID: 17566666 [TBL] [Abstract][Full Text] [Related]
13. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression. Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927 [TBL] [Abstract][Full Text] [Related]
14. Extramedullary blast crisis in chronic myeloid leukemia--a case report. Tondon R; Singh PA; Misra V; Singh M; Mohan S Indian J Pathol Microbiol; 2005 Apr; 48(2):253-4. PubMed ID: 16758687 [TBL] [Abstract][Full Text] [Related]
15. Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis. Olsson-Strömberg U; Aleskog A; Björnberg A; Höglund M; Simonsson B; Bengtsson M; Barbany G; Larsson R; Lindhagen E Anticancer Drugs; 2006 Jul; 17(6):631-9. PubMed ID: 16917208 [TBL] [Abstract][Full Text] [Related]
16. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings. Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654 [TBL] [Abstract][Full Text] [Related]
17. Extramedullary blast crisis of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation mimicking aggressive, translocation t(14;18)-positive B-cell lymphoma. Kroschinsky F; Friedrich K; Hanel M; Mohr B; Langer T; Meinhardt M; Thiede C; Bornhauser M; Baretton G; Ehninger G Ann Hematol; 2003 Jan; 82(1):47-52. PubMed ID: 12574966 [TBL] [Abstract][Full Text] [Related]
18. Acute bilineage leukemia after chronic myelogenous leukemia. Williams SR; Wellhausen SR; Barker RL; Janckila AJ J Ky Med Assoc; 1997 Sep; 95(9):393-6. PubMed ID: 9322413 [TBL] [Abstract][Full Text] [Related]
19. [Blast differentiation in a patient with chronic myeloid leukemia in blast crisis using retinoic acid]. Burgaleta C; Villalba S; Ferro MT Sangre (Barc); 1995 Dec; 40(6):509-12. PubMed ID: 8850236 [TBL] [Abstract][Full Text] [Related]
20. A comment on Megakaryocytic blast crisis as a presenting manifestation of chronic myeloid leukemia. Lazarevic VLj Leuk Res; 2010 Sep; 34(9):1253. PubMed ID: 20378169 [No Abstract] [Full Text] [Related] [Next] [New Search]